Literature DB >> 28767139

Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes.

Alyson L Mahar1, Carolyn Compton2,3, Susan Halabi4, Kenneth R Hess5,6, Martin R Weiser7, Patti A Groome1.   

Abstract

Integrating diverse types of prognostic information into accurate, individualized estimates of outcome in colorectal cancer is challenging. Significant heterogeneity in colorectal cancer prognostication tool quality exists. Methodology is incompletely or inadequately reported. Evaluations of the internal or external validity of the prognostic model are rarely performed. Prognostication tools are important devices for patient management, but tool reliability is compromised by poor quality. Guidance for future development of prognostication tools in colorectal cancer is needed.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  clinical prediction tool; colorectal neoplasms; nomogram; prognosis

Mesh：

Year:  2017        PMID： 28767139      PMCID： PMC5760443          DOI： 10.1002/jso.24774

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  83 in total

1.  Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.

Authors:  Vincenzo Valentini; Ruud G P M van Stiphout; Guido Lammering; Maria Antonietta Gambacorta; Maria Cristina Barba; Marek Bebenek; Franck Bonnetain; Jean-Francois Bosset; Krzysztof Bujko; Luca Cionini; Jean-Pierre Gerard; Claus Rödel; Aldo Sainato; Rolf Sauer; Bruce D Minsky; Laurence Collette; Philippe Lambin
Journal:  J Clin Oncol       Date:  2011-07-11       Impact factor: 44.544

2.  Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients.

Authors:  C H Köhne; D Cunningham; F Di Costanzo; B Glimelius; G Blijham; E Aranda; W Scheithauer; P Rougier; M Palmer; J Wils; B Baron; F Pignatti; P Schöffski; S Micheel; H Hecker
Journal:  Ann Oncol       Date:  2002-02       Impact factor: 32.976

3.  NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

Authors:  Phillip G Febbo; Marc Ladanyi; Kenneth D Aldape; Angelo M De Marzo; M Elizabeth Hammond; Daniel F Hayes; A John Iafrate; R Kate Kelley; Guido Marcucci; Shuji Ogino; William Pao; Dennis C Sgroi; Marian L Birkeland
Journal:  J Natl Compr Canc Netw       Date:  2011-11       Impact factor: 11.908

4.  Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study.

Authors:  Benoist Chibaudel; Franck Bonnetain; Christophe Tournigand; Leila Bengrine-Lefevre; Luis Teixeira; Pascal Artru; Jérôme Desramé; Annette K Larsen; Thierry André; Christophe Louvet; Aimery de Gramont
Journal:  Oncologist       Date:  2011-08-22

5.  Predicting survival after curative colectomy for cancer: individualizing colon cancer staging.

Authors:  Martin R Weiser; Mithat Gönen; Joanne F Chou; Michael W Kattan; Deborah Schrag
Journal:  J Clin Oncol       Date:  2011-11-14       Impact factor: 44.544

6.  Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases.

Authors:  K J Roberts; A White; A Cockbain; J Hodson; E Hidalgo; G J Toogood; J P A Lodge
Journal:  Br J Surg       Date:  2014-06       Impact factor: 6.939

7.  Revised TN categorization for colon cancer based on national survival outcomes data.

Authors:  Leonard L Gunderson; John Milburn Jessup; Daniel J Sargent; Frederick L Greene; Andrew K Stewart
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544

8.  A prognostic score for colorectal cancer.

Authors:  Nuri A Kama; Murat Kologlu; Erhan Reis; Mutlu Doganay; Mesut Atli; Mete Dolapci
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct

9.  Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases.

Authors:  Hassan Z Malik; K Rajendra Prasad; Karim J Halazun; Amir Aldoori; Ahmed Al-Mukhtar; Dhanwant Gomez; J Peter A Lodge; Giles J Toogood
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

10.  Selection criteria for radiofrequency ablation for colorectal liver metastases in the era of effective systemic therapy: a clinical score based proposal.

Authors:  Axel Stang; Karl Jürgen Oldhafer; Hauke Weilert; Handan Keles; Marcello Donati
Journal:  BMC Cancer       Date:  2014-07-09       Impact factor: 4.430
View more
  37 in total

1.  Critical appraisal of predictive tools to assess the difficulty of laparoscopic liver resection: a systematic review.

Authors:  Julie Hallet; Patrick Pessaux; Kaitlyn A Beyfuss; Shiva Jayaraman; Pablo E Serrano; Guillaume Martel; Natalie G Coburn; Tullio Piardi; Alyson L Mahar
Journal:  Surg Endosc       Date:  2018-10-22       Impact factor: 4.584

2.  The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma.

Authors:  Fabio Bagante; Katiuscha Merath; Malcolm H Squires; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Olivier Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-01-19       Impact factor: 3.452

3.  Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).

Authors:  En Cheng; Fang-Shu Ou; Chao Ma; Donna Spiegelman; Sui Zhang; Xin Zhou; Tiffany M Bainter; Leonard B Saltz; Donna Niedzwiecki; Robert J Mayer; Renaud Whittom; Alexander Hantel; Al Benson; Daniel Atienza; Michael Messino; Hedy Kindler; Edward L Giovannucci; Erin L Van Blarigan; Justin C Brown; Kimmie Ng; Cary P Gross; Jeffrey A Meyerhardt; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2022-01-07       Impact factor: 44.544

4.  High expression of MAGE-C1 gene in colorectal cancer is associated with its poor prognosis.

Authors:  Yu Tian; Ping Liang; Lihua Zhang; Xiufen Zhang; Xiaoli Wang; Yufen Jin; Xiaowei Qi; Yankui Liu
Journal:  J Gastrointest Oncol       Date:  2021-12

Review 5.  Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update.

Authors:  Kaibin Chang; Lei Jiang; Yifeng Sun; He Li
Journal:  Mol Diagn Ther       Date:  2022-06-22       Impact factor: 4.476

6.  External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort.

Authors:  Karen Bolhuis; G Emerens Wensink; Marloes A G Elferink; Marinde J G Bond; Willemieke P M Dijksterhuis; Remond J A Fijneman; Onno W Kranenburg; Inne H M Borel Rinkes; Miriam Koopman; Rutger-Jan Swijnenburg; Geraldine R Vink; Jeroen Hagendoorn; Cornelis J A Punt; Sjoerd G Elias; Jeanine M L Roodhart
Journal:  Cancers (Basel)       Date:  2022-05-10       Impact factor: 6.575

Review 7.  Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic.

Authors:  S Bennett; K Søreide; S Gholami; P Pessaux; C Teh; E Segelov; H Kennecke; H Prenen; S Myrehaug; D Callegaro; J Hallet
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677

8.  Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection of Stage I-III Colon Cancer.

Authors:  Martin R Weiser; Meier Hsu; Philip S Bauer; William C Chapman; Iván A González; Deyali Chatterjee; Deepak Lingam; Matthew G Mutch; Ajaratu Keshinro; Jinru Shia; Efsevia Vakiani; Tsuyoshi Konishi; Yoshifumi Shimada; Zsofia Stadler; Neil H Segal; Andrea Cercek; Leonard Saltz; Rona Yaeger; Anna Varghese; Maria Widmar; Iris H Wei; Emmanouil P Pappou; J Joshua Smith; Garrett Nash; Philip Paty; Julio Garcia-Aguilar; Mithat Gonen
Journal:  J Clin Oncol       Date:  2021-01-13       Impact factor: 44.544

9.  Upregulated long intergenic non-protein coding RNA 1094 (LINC01094) is linked to poor prognosis and alteration of cell function in colorectal cancer.

Authors:  Guangliang Zhang; Yingjie Gao; Zhen Yu; Hui Su
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

10.  Nuclear IGF1R interacts with NuMA and regulates 53BP1‑dependent DNA double‑strand break repair in colorectal cancer.

Authors:  Chen Yang; Yifan Zhang; Nelly Segar; Changhao Huang; Pengwei Zeng; Xiangzhou Tan; Linfeng Mao; Zhikang Chen; Felix Haglund; Olle Larsson; Zihua Chen; Yingbo Lin
Journal:  Oncol Rep       Date:  2021-06-24       Impact factor: 3.906
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.